Medexus Pharmaceuticals Initiates Offering of Common Shares

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Kickoff at Central Grove: What’s Brewing? Ever wander through Kearneysville, W.Va., and wonder what’s going on with that bustling crew near Goldenrod Drive? The folks at West Virginia American Water have kicked off groundwork for the much-anticipated Central Grove Water Treatment Plant. This, comrades, isn’t just some shiny new shed we’re talking about. Oh no,...

AI Takes Center Stage in Construction Ever seen AI shake a dusty old industry to its core? Well, if you haven't, ANDPAD is doing just that in construction, making waves across Asia. Look, when a company like ANDPAD snags a spot in the 'NextGen Tech 30 2026,' you pay attention. That's a glitzy award for the movers and shakers in tech, and these folks are doing some serious...

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

The wheels are literally in motion in South Broward, with Memorial Healthcare System's Mobile Health Program taking healthcare to the doorstep of thousands. This killer initiative slashed hospital admissions by a nifty 62% among its users in 2025, and they ain't slowing down in 2026. Talk about bringing the doctor to the streets and changing lives! Healthcare On Wheels:...

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Cracking Open Brookdale's Q3 2026 Numbers: A Mixed Bag You know, there's something oddly satisfying about net losses shrinking like a cheap wool sweater in a hot wash. Brookdale Senior Living's third quarter results show just that. We're looking at a net loss of $13.9 million, a big step up from the towering $114.7 million nosedive a year ago. Yeah, it's still a loss, but...

The Power of Building a Legacy There I was, watching the home the VFW built not just with nails and beams, but conviction. In a world where construction and legacy often don't speak the same language, the Frederick VFW Post 3285 is flipping the script. We're looking at a story about real, tangible impact—not in the P&Ls but in actual lives. Brick by Brick: A...

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Market Challenges Impacting Harris & Harris Group In the current challenging market landscape, shares of Harris & Harris Group, Inc. (NASDAQ: TURN) have hit a 52-week low of $3.3. This investment firm, known for its venture capital endeavors, has encountered substantial difficulties over the past year, evidenced by a notable decline of 19.76%. Such a downturn reflects...

Innovative Approaches for Lead Exposure Detection Lead exposure can have serious consequences on health, and it is crucial to have effective methods for its detection. A team at Purdue University has pioneered transformative technologies that streamline the process of measuring lead exposure in blood and bone tissues. The innovations developed offer significant benefits...

Devon Energy Engages with Investors at J.P. Morgan Conference Devon Energy Corp. (NYSE: DVN) is gearing up for an exciting opportunity to engage directly with investors. Clay Gaspar, the company’s President and CEO, will be participating in a fireside chat at the prestigious J.P. Morgan Energy, Power, Renewables & Mining Conference. This event promises to be informative...

Recent Developments in the Spanish Stock Market The Spanish stock market experienced a downturn recently, closing lower amid notable sectoral losses. The primary sectors that faced declines included Telecoms & IT, Building & Construction, and Chemical, Petroleum & Plastic. These pullbacks adversely affected many stocks, particularly within the IBEX 35 index. IBEX 35...

Oppenheimer Maintains Perform Rating on GDEV Inc. Oppenheimer has decided to keep its Perform rating on shares of GDEV Inc. (NASDAQ: GDEV), focusing on the exciting growth avenues being explored for the company's PG3 game. The firm notes that while PG3 currently constitutes less than 10% of GDEV's overall revenues, it is strategically placed for future expansion. Future...